Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
2.
J Immunol ; 160(10): 5058-65, 1998 May 15.
Article in English | MEDLINE | ID: mdl-9590256

ABSTRACT

In the intestine, lung, and urinary tract, neutrophil (polymorphonuclear leukocyte, PMN) transepithelial migration is dependent on the leukocyte beta2 integrin CD11b/CD18. While the regions of CD11b involved in recognition of several soluble ligands are known, those that mediate PMN-epithelial interactions have not been investigated. In this study, mAbs reactive with four extracellular regions on CD11b, the NH2-terminal region, I (inserted) domain, cation-binding region, and region proximal to the transmembrane domain (C domain), were analyzed for the ability to block CD11b/CD18-mediated interactions with T84 intestinal epithelial cells. In such a manner, epitope mapping was applied to the complex interactions between CD11b/CD18 and a cell-based ligand system. I domain Abs strongly inhibited both adhesion of PMN to epithelial cells and PMN migration across T84 epithelial monolayers. However, the profile of inhibition was distinct from that of other known ligands of CD11b/CD18. CBRM1/32, an Ab to a discontinuous epitope residing within the NH2- and cation-binding domains, strongly inhibited both adhesion and transmigration responses. C domain Abs had minimal effects on adhesion and transmigration. These findings appear applicable to other epithelia, since similar results were obtained in transmigration experiments with CF15 human airway epithelial cells. Finally, Ab inhibition profiles were confirmed with adhesion assays of isolated epithelial cells to purified CD11b/CD18. These findings demonstrate the central role of the I domain and the participation of a discontinuous region shared by the NH2- and cation-binding domains in mediating PMN-adhesive interactions with epithelial cells.


Subject(s)
Cell Communication , Epitope Mapping , Macrophage-1 Antigen/physiology , Neutrophils/physiology , Antibodies, Monoclonal/immunology , Cell Adhesion , Cell Movement , Cells, Cultured , Epithelial Cells/physiology , Humans , Intercellular Adhesion Molecule-1/physiology , Macrophage-1 Antigen/immunology
4.
Mol Endocrinol ; 8(1): 59-68, 1994 Jan.
Article in English | MEDLINE | ID: mdl-8152431

ABSTRACT

Activating transcription factor-3 (ATF-3) is one member of a large family of leucine zipper transcription factors which bind to promoters responsive to cAMP and phorbol ester at the related cAMP (CRE) and phorbol ester response elements. We report here that ATF-3 is coexpressed with the neuropeptide precursor proenkephalin in human neuroblastoma SK-N-MC cells. Cotransfection experiments indicate that activation of proenkephalin gene expression by ATF-3 is dependent upon both the catalytic subunit of the cAMP-dependent protein kinase and the CRE-2 element. The CRE-2 element is essential for second messenger-inducible expression and is known to bind AP-1-like transcription factors. ATF-3 expressed in bacteria or from rabbit reticulocyte lysates binds to the proenkephalin CRE-2 element as a homodimer and as a heterodimer with Jun-D, another activator of proenkephalin transcription. ATF-3 stimulates binding of Jun-D to the proenkephalin CRE-2 element and acts synergistically with Jun-D to induce proenkephalin gene expression. Sequential immunoprecipitations of ATF-3 from SK-N-MC cells expressing proenkephalin indicate that ATF-3 is complexed with Jun-D in vivo and that both proteins are highly phosphorylated. Together, our results suggest that ATF-3 may play an important role in the regulation of gene expression by cAMP-dependent intracellular signaling pathways.


Subject(s)
Cyclic AMP/pharmacology , Gene Expression/drug effects , Transcription Factors/pharmacology , Activating Transcription Factor 3 , Base Sequence , Binding Sites , DNA/metabolism , Drug Synergism , Enkephalins/genetics , Humans , Leucine Zippers , Macromolecular Substances , Molecular Sequence Data , Neuroblastoma/metabolism , Phosphorylation , Protein Precursors/genetics , Proto-Oncogene Proteins c-jun/metabolism , Proto-Oncogene Proteins c-jun/pharmacology , Recombinant Fusion Proteins , Signal Transduction , Transcription Factors/genetics , Transcription Factors/metabolism , Transfection , Tumor Cells, Cultured , beta-Galactosidase/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...